AKEBIA THERAPEUTICS, INC. Preferred Stock Dividends and Other Adjustments
AKEBIA THERAPEUTICS, INC. (AKBA) reported Preferred Stock Dividends and Other Adjustments of $86.90 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-04.
Discontinued › Expense Statement › Operating Expenses
us-gaap:PreferredStockDividendsAndOtherAdjustments · last filed 2015-03-04
- AKEBIA THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2014-12-31 was $0.00, a 100.00% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2014-09-30 was -$555.00, a 100.02% decline year-over-year.
- AKEBIA THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2013-12-31 was $3.02M.
- AKEBIA THERAPEUTICS, INC. preferred stock dividends and other adjustments for the quarter ending 2013-09-30 was $2.75M.
- AKEBIA THERAPEUTICS, INC. preferred stock dividends and other adjustments for fiscal 2014 was $86.90M, a 55.49% increase from fiscal 2013.
- AKEBIA THERAPEUTICS, INC. preferred stock dividends and other adjustments for fiscal 2013 was $55.89M, a 1581.79% increase from fiscal 2012.
- AKEBIA THERAPEUTICS, INC. preferred stock dividends and other adjustments for fiscal 2012 was $3.32M.
| Period end | Preferred Stock Dividends and Other Adjustments 3 month | Preferred Stock Dividends and Other Adjustments 6 month | Preferred Stock Dividends and Other Adjustments 9 month | Preferred Stock Dividends and Other Adjustments 12 month | Preferred Stock Dividends and Other Adjustments 85 month |
|---|---|---|---|---|---|
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | -$555.00 derived: sum of 2 quarters · filed 2015-03-04 | $86.90M 10-K · filed 2015-03-04 | ||
| 2014-09-30 | -$555.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $86.90M 10-Q · filed 2014-11-10 | |||
| 2014-06-30 | $86.90M 10-Q · filed 2014-08-11 | ||||
| 2014-03-31 | $153.64M 10-Q · filed 2014-05-12 | ||||
| 2013-12-31 | $3.02M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-04 | $5.77M derived: sum of 2 quarters · filed 2015-03-04 | $55.04M derived: sum of 3 quarters · filed 2015-03-04 | $55.89M 10-K · filed 2015-03-04 | |
| 2013-09-30 | $2.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $52.01M derived: sum of 2 quarters · filed 2014-11-10 | $52.86M 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $49.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $50.11M 10-Q · filed 2014-08-11 | |||
| 2013-03-31 | $848.13K 10-Q · filed 2014-05-12 | ||||
| 2012-12-31 | $3.32M 10-K · filed 2015-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |